Showing results (1-10 of 32) with videos related to
Sort By:
Pageof 4
Brain Research|April 9, 1990
Differential effects of D1 and D2 dopamine receptor agonists on substantia nigra pars reticulata neuronsB L WaszczakNeuropharmacology|August 1, 1983
Diazepam potentiates GABA-, but not adenosine-mediated, inhibition of neurons of the nigral pars reticulataB L WaszczakEuropean Journal of Pharmacology|August 22, 1980
Intravenous GABA agonist administration stimulates firing of A10 dopaminergic neuronsB L Waszczak, J R WaltersEuropean Journal of Pharmacology|June 18, 1991
Autoradiography of dopamine D2 receptors using [3H]YM-09151-2R F Cox, B L WaszczakThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 1994
D1 agonist-induced excitation of substantia nigra pars reticulata neurons: mediation by D1 receptors on striatonigral terminals via a pertussis toxin-sensitive coupling pathwayL P Martin, B L WaszczakThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 1, 1986
Endogenous dopamine can modulate inhibition of substantia nigra pars reticulata neurons elicited by GABA iontophoresis or striatal stimulationB L Waszczak, J R WaltersBrain Research|August 12, 1996
Dopamine D2, receptor-mediated modulation of the GABAergic inhibition of substantia nigra pars reticulata neuronsL P Martin, B L WaszczakBrain Research|November 26, 1990
Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysisR F Cox, B L WaszczakBrain Research|June 4, 1993
Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinolineR F Cox, B L WaszczakEuropean Journal of Pharmacology|October 15, 1984
A physiological role for dopamine as modulator of GABA effects in substantia nigra: supersensitivity in 6-hydroxydopamine-lesioned ratsB L Waszczak, J R WaltersPageof 4